PHP
LNTH icon

Parkman Healthcare Partners’s Lantheus LNTH Stock Holding History

Parkman Healthcare Partners’s Portfolio LNTH Stock Details LNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-80,000
Closed -$4.96M – 109
2023
Q4 		$4.96M Buy
80,000
+30,111
+60% +$2.04M 0.7% 45
2023
Q3 		$3.47M Sell
49,889
-195,658
-80% -$14.3M 0.64% 46
2023
Q2 		$20.6M Buy
245,547
+58,360
+31% +$5.24M 3.57% 6
2023
Q1 		$15.5M Buy
187,187
+96,264
+106% +$6.21M 3.36% 5
2022
Q4 		$4.63M Buy
90,923
+51,241
+129% +$3.16M 1.23% 31
2022
Q3 		$2.79M Buy
39,682
+18,255
+85% +$1.38M 0.79% 49
2022
Q2 		$1.42M Sell
21,427
-3,868
-15% -$244K 0.52% 51
2022
Q1 		$1.4M Buy
+25,295
New +$949K 0.41% 57

Other funds holding LNTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Parkman Healthcare Partners's LNTH Position: Q1 2024 in Review

Parkman Healthcare Partners sold out of Lantheus (LNTH) in Q1 2024, closing a stake of 80,000 shares — an estimated $4.96M sold.

Parkman Healthcare Partners first reported a position in LNTH in Q1 2022 and held it in 8 quarters. The position peaked at $20.6M in Q2 2023. 411 funds tracked by Wall St. Rank hold LNTH as of Q1 2024.

  • Parkman Healthcare Partners reported no remaining Lantheus position as of Q1 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 80,000 Lantheus shares in Q1 2024, an estimated $4.96M.
  • Parkman Healthcare Partners first reported a position in Lantheus in Q1 2022 and held it in 8 quarters.
  • Parkman Healthcare Partners's Lantheus position peaked at $20.6M in Q2 2023.
  • 411 funds tracked by Wall St. Rank held Lantheus as of Q1 2024.

Based on Parkman Healthcare Partners's 13F filing for Q1 2024, filed 15 May 2024.